BLCO as reported
Bausch + Lomb Corporation reported $5.21B of revenue over the trailing twelve months, +7.8% on the year before. 9 reported series are charted on this page, each one as filed.
$5.21B
Revenue, trailing twelve months · to Q1 2026 · +7.8% against the twelve months before
- Net Income
- −$219M
Net Income · −40% year on year · trailing twelve months to Q1 2026
- Free Cash Flow
- $1.0M
Free Cash Flow · −101% year on year · trailing twelve months to Q1 2026
- Op Margin
- 4.3%
Op Margin · trailing twelve months to Q1 2026
| Series | Latest | Year on year | As of |
|---|---|---|---|
| Revenue | $5.21B | +7.8% | Q1 2026 |
| Net Income | −$219M | −40% | Q1 2026 |
| EPS | −$0.63 | −39% | Q1 2026 |
| Op Margin | 4.3% | n/a | Q1 2026 |
| Net Margin | −4.2% | n/a | Q1 2026 |
| ROE | −4.5% | n/a | Q1 2026 |
| ROA | −2.1% | n/a | Q1 2026 |
| ROIC | 0.83% | n/a | Q1 2026 |
| Free Cash Flow | $1.0M | −101% | Q1 2026 |
Every figure straight from the statements as filed with the SEC, no scoring, no adjustment. Open a series for its full history.
Bausch + Lomb Corporation (BLCO) - Revenue & ProfitRevenue & ProfitBausch + Lomb Corporation (BLCO)
Revenue (TTM)Net Income (TTM)
Powered byryufin.com
Medical Instruments & Supplies
Ranks #7 of 27 by Smart Score